ARS Pharmaceuticals, Inc. (SPRY)

NASDAQ: SPRY · IEX Real-Time Price · USD
6.32
-0.08 (-1.25%)
Jan 27, 2023, 4:00 PM EST - Market closed

Stock Price Forecast

According to 7 stock analysts, the average 12-month stock price forecast for SPRY stock is $14.28, which predicts an increase of 125.95%. The lowest target is $14.14 and the highest is $14.7. On average, analysts rate SPRY stock as a buy.
Analyst Consensus: Buy
Target Low Average Median High
Price $14.14 $14.28 $14.28 $14.7
Change +123.73% +125.95% +125.95% +132.59%

Analyst Ratings

The average analyst rating for SPRY stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Dec '22Jan '23
Strong Buy 03
Buy 03
Hold 31
Sell 10
Strong Sell 20
Total 67

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.11
from -2.56
EPS Next Year
-2.21
from -2.11
Year 201820192020202120222023202420252026
Revenue
-------144.89M218.69M
Revenue Growth
--------
50.94%
EPS
-29.11-36.27-11.33-2.56-2.11-2.21-2.25-0.080.46
EPS Growth
---------
No. Analysts ----44443

Revenue Forecast

Revenue 20222023202420252026
High n/a n/a n/a 172.6M 225.1M
Avg n/a n/a n/a 144.9M 218.7M
Low n/a n/a n/a 117.3M 210.1M

Revenue Growth

Revenue Growth 20222023202420252026
High - - - -
55.4%
Avg - - - -
50.9%
Low - - - -
45.0%

EPS Forecast

EPS 20222023202420252026
High -2.17 -2.28 -2.32 -0.05 0.47
Avg -2.11 -2.21 -2.25 -0.08 0.46
Low -2.03 -2.13 -2.17 -0.11 0.44

EPS Growth

EPS Growth 20222023202420252026
High - - - - -
Avg - - - - -
Low - - - - -
Sources: Price target, rating and forecast data provided by Finnhub and sourced from Wall Street analysts and other sell-side and buy-side analysts and investors. Data disclaimer.